chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Tired; nervousness; Memory loss; had a little temperature; weird sensation in her vagina and thinks it might be a yeast infection; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Tired), NERVOUSNESS (nervousness), AMNESIA (Memory loss), PYREXIA (had a little temperature) and VULVOVAGINAL DISCOMFORT (weird sensation in her vagina and thinks it might be a yeast infection) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027AG1A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On 02-Mar-2021, the patient experienced FATIGUE (Tired), NERVOUSNESS (nervousness), AMNESIA (Memory loss), PYREXIA (had a little temperature) and VULVOVAGINAL DISCOMFORT (weird sensation in her vagina and thinks it might be a yeast infection). At the time of the report, FATIGUE (Tired), NERVOUSNESS (nervousness), AMNESIA (Memory loss), PYREXIA (had a little temperature) and VULVOVAGINAL DISCOMFORT (weird sensation in her vagina and thinks it might be a yeast infection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication was not provided.   Reporter did not allow further contact
Palpitations & HYPERtension Received Moderna booster on 1/13/2022 at 08:45 and heart palpitations and elevated blood pressures started at 1800 1/14/2022 Blood pressure 137/85, Pulse 104 Patient states blood pressure usually runs in 110's over 70's and no history of irregular heart rate Patient had EKG 1/13/2022 that showed in heart rate, was told EKG ok, but Blood pressure elevated and heart increased - to follow up in ER if symptoms worsened. Employee has appointment with cardiologist 1/14/2022 for evaluation.
Severe chest pain, pain in jaw, brow bones and headache (may have been due to GERD- acid reflux disease), symptoms started at 11:30PM while in bed and lasted 1-2 hours; sudden onset and dissipation
got really sick, got so sick that he need to laid down on the floor; she said he was "pale as a ghost"; was so nauseaous he need to laid down on the floor; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (got really sick, got so sick that he need to laid down on the floor), PALLOR (she said he was "pale as a ghost") and NAUSEA (was so nauseaous he need to laid down on the floor) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 061E21A, 02UD21A and 04UA21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In October 2021, the patient experienced PALLOR (she said he was "pale as a ghost") and NAUSEA (was so nauseaous he need to laid down on the floor). On 28-Oct-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced ILLNESS (got really sick, got so sick that he need to laid down on the floor). At the time of the report, ILLNESS (got really sick, got so sick that he need to laid down on the floor) and NAUSEA (was so nauseaous he need to laid down on the floor) outcome was unknown and PALLOR (she said he was "pale as a ghost") had not resolved.            No Concomitant medication was reported Patient is not sure if he took Motrin or ibuprofen to treat his symptoms
15 hours after vaccine - headache, mild fever, severe body aches 39 hours after vaccine - period of extreme exhaustion 42 hours after vaccine - all prior symptoms subsided 80+ hours after vaccine - body covered in itchy rashes and hives (current symptom)
Started with headaches 8/18/12 had a CT, MRI, was on 2400 mg. MOTRIN, IMITREX and then on Prednisone. 1 wk. supply, went to hospital on 9/5/12. Had 2 biopsies done. Results were positive for temporal arteritis. I am on high doses of Prednisone, will wean doses to 10 mg - will stay on 10 mg. for quite a long time.
dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizziness). At the time of the report, DIZZINESS (dizziness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant history and concomitant medications were reported. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jun-2021: No specific follow-up information recorded.
Information has been received from a 31 year old female consumer, for GARDASIL, a Pregnancy Registry product, reporting herself with no pertinent medical history and drug reactions who was vaccinated her first dose of GARDASIL in March 2011 and her second dose of GARDASIL on 28-SEP-2011. There was no concomitant medication. On 09-NOV-2011 the patient went to the office and had a urine pregnancy test with a positive result. The patient was 5.5 weeks pregnant", the date of last menstrual period was 03-OCT-2011 and the estimated delivery date was 09-JUL-2012. No treatment was given for adverse event. It was also indicated that the patient is over 26 years old. No adverse effects were reported. The therapy was discontinued. Additional information was received from Registered Nurse regarding the 31 year old female patient. The physician was unavailable at that time. The phone call was transferred to the registered nurse who stated that the patient was induced at 36 weeks due to hypertension and anemia. The patient gave birth on 14-JUN-2012. The infant, (boy) had no congenital anomalies and birth weight was 4 pounds 10 ounces. The patient has not received any further GARDASIL vaccines. There was no information regarding the infant's pediatrician. Outcome of hypertension and anemia was unknown. Causality was not reported. Additional information is not expected. Additional information has been requested.
From telephone call on 6/1/01, it was stated that a 10 year old female pt received her 4th dose of Imovax Rabies, IM, lot #R0958, on 5/29/01. The pt experienced headache, nausea and vomiting on 5/30/01. Further information requested.
Low Blood sugar; had the fever after given half an hour suddenly; I got really sick; This is a spontaneous report from a contactable consumer (patient). A 25-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number was not reported, expiration date was not reported), via an unspecified route of administration on 20Apr2021 (at the age of 25-years-old) as dose 1, single for covid-19 immunization. The patient medical history was not reported. There were no concomitant medications. It was reported that patient had the vaccine (Further clarification was unknown hence captured as unspecified vaccine) shot on tuesday and wednesday night on 21Apr2021 around 6pm he started having really he guess bad effects like he got low blood sugar. He got really sick. He actually had the fever after given half an hour suddenly. He was wandering is this the allergic reaction to shot. The outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Initial health care professional report received on 10 Mar 2010: This patient received expired FLUVIRIN, 0.5ml intramuscular on an unknown date in Mar 2010, sometime between 01 Mar 2010 and 09 Mar 2010. None other adverse events was reported.
Pt received Pfizer vaccines on 05/16/21 and 06/06/21. Pt presented to the ED on 12/02/21 for an emergent colonoscopy. Pt was tested for COVID on 12/06/21. Pt did not have a fever and was no hypoxic.
Within 20 minutes of injection, I experienced severe shortness of breath, heart palpatations, throat tightening, dizziness, wheezing, pallor. I was close enough to a facility to drive myself there, thankfully.
two arm plaques; This spontaneous case was reported by a physician and describes the occurrence of SKIN PLAQUE (two arm plaques) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SKIN PLAQUE (two arm plaques). At the time of the report, SKIN PLAQUE (two arm plaques) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.    This case was linked to MOD-2021-327027, MOD-2021-327034 (Patient Link).
giant hives; Initial information received on 06-Dec-2020 regarding an unsolicited valid serious social media case from a consumer (Patient) via social media.  This case involves a patient of unknown demographics who experienced giant hives (angioedema), while patient received INFLUENZA VACCINE.  The patient's medical treatments, vaccinations, concomitant medication and family history were not provided.  At the time of the event, the patient had ongoing medical history of allergy to vaccine for which patient was use to wear mask every year from October through March.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiration date not reported) via an unknown route at unknown administration site for prophylactic vaccination.  On an unknown date, the patient experienced giant hives (angioedema) unknown latency following the administration of INFLUENZA VACCINE.  It was reported that the shot does not give you the flu.  No relevant laboratory data was reported.   It was not reported if the patient received a corrective treatment.  The event outcome was unknown, at the time of reporting.  Information on the batch number was requested for this case.; Sender's Comments: This case concerns an patient of unknown demographics who presented with giant case hives after vaccination with INFLUENZA VACCINE. The time to onset is unknown. The patient had prior allergy to vaccine. Moreover, concomitant medications, patient's medical condition and laboratory tests ruling out alternate etiologies were not reported. Based upon the reported information, the role of the vaccine cannot be assessed.
Aug.24, second Gardasil injection received. Sept.3, pressure in jaw and head began, followed by weakness, severe pain and loss of use of legs; nausea, dizziness, fainting, swelling and drooping of face and neck. Oct.2007, lost ability to walk, burning prickles in scalp, hands, legs. Seen by several specialists including hospital neurological teams- no diagnosis given. Seen by multiple specilists Jan. 2008 - June 2008. Unable to eat solid foods, placed on liquid diet. Finally diagnosed by D.O. as having an adverse reaction to Gardasil. Special diet and pain medication given which seem to be helping in small degrees. We were told it would be a long time recovering.  2nd report 320256. 07/23/2008 MR received for DOS 10/19-24/2007 which include 2 Rheumatology consults, neuro consult, psych consult and inpt admission. Pt presented for Rheum eval 10/19/07 with c/o 6 week hx of pain and sensitivity in her face, jaw neck and thoracic region (burning & tingling) and progressive weakness in her limbs.  Unable to walk without assistance. Pt reports dizziness, vertigo, syncope and photosensitivity. Sleep is disturbed. Several falls. Has sweats. Presents in sunglasses for photophobia and in a w/c. This followed a viral and /or sinus infection 6 weeks prior. PE (+) for anceiform rash on the back, scalp, face, jaw, and neck tenderness, DTRs 1+ arms, unobtainable in legs, decreased strength in arms and legs, unable to walk.  Concern for neurological illness resulted in emergent admission to hospital for further eval. DOS 10/19-24/2007 with DX: weakness.  other dx:  fibromyalgia, migraines, asthma and chronic pain syndrome. Neuro consult as above but able to elicit patellar reflexes. Psych eval to r/o conversion d/o. Requested further eval. 2nd Rheum consult for increased sed rate. Additional sx of touch sensitivity and lower extremity numbness.  Impression:  Elevated Sed rate.  Myalgia and myositis NOS, Headache, Difficulty in walking. Pt had some nausea and vomiting while admitted.  Treated for pain and pt was ambulating on her own by d/c.  No final dx made.  D/C to f/u at home. 4/6/09 Received call from pt's current MD.  Has not been able to fully evaluate pt as pt has been unable to travel.  Unable to confirm GBS dx. Current dx is conversion d/o./pc 1/25/2010 Follow up: She is considered disabled due to the GARDASIL vaccine. SHe has perpherial neuropathy in both legs (from the knees down) she has nervous systmen pain; brain fog; eye sensitivity/abnormal pupuilary responsive and dilations; GI tract disorders.
Dizziness, Headache, Fever, Diarrhea, Syncope, chills, congestion, dyspnea, fatigue, rigors, injection site pain/arm pain, swelling at injection site Narrative:  Other Relevant History:
promptly p/vax pt produced redness around rt leg;no signs of grave rxn noted;pt injected w/.2ml of DPH & observed & disch 30min later;
Breakthrough case of COVID-19. Symptoms started 06/19/22 and tested positive with Rapid Home test later that day. Started Course of Paxlovid on 06/20/22.
This medically confirmed spontaneous report (initial receipt 28-Oct-2014) concerns a 53 year old male patient. On 26-Oct-2014, AFLURIA underwent temperature excursion at 50 degree Fahrenheit for undetermined amount of time. On 27-Oct-2014, the patient received temperature excursioned AFLURIA, (batch number: T50507) via intramuscular route at 0.5 ml. Outcome was reported as unknown. Reporter's comments: The reporter assessed the event as non-serious.
the evenning of the vacine (prevnar 13), my arm started to hurt and its warm, and i have body ache, chill, headache, a fever 100.4, and my arm continue to hurt more and gotten hotter, this last from Fri-Sun.  on Mon, my arm start to turn red and the continue to feel burning for about 3 more days and the redness gone down 70% by 6/3/22, then on the next Sun 6/5, my skin started to peeling.   but by this time all the other symptoms disappear, now its just peeling.  i never have this kind of reaction to any vaccine before.
Patient received Moderna COVID-19 vaccine on 5/8/2021 and developed redness at the site (the day of the injection). Area was very sensitive to the touch for the first 12 hours. Starting 5/9/2021, patient developed swelling at the site of injection, which extended from the site of injection all the way to the wrist area. This persisted for about 7 days. Reaction has now resolved.
MOM BROUGHT CHILD INTO OFFICE ON 8/4/2010 STATING CHILD HAD AN ALLERGIC REACTION TO HER VACCINE RIGHT AFTER IT WAS GIVEN.  MOM SAYS THE BRIDGE OF HER NOSE WAS SWOLLEN, EYES WERE A LITTLE PUFFY, CHEEKS WERE RED, AND VACCINE SITE WAS RED AND BLOTCHY.  MOM SAYS SHE TRIED TO TAKE HER TO THE DR. BUT DR. WAS NOT IN AND THE OFFICE STAFF TOLD HER TO COME TO THE HEALTH DEPARTMENT.  CHILD HAS SLIGHT PUFFINESS AT BRIDGE OF NOSE AND AROUND THE EYES, CHEEKS ARE ROSEY, AND THE VACCINE SITE IS RED AND BLOTCHY AND COVERS THE ENTIRE AREA OF THE LEFT DELTOID AREA.  CHILD HAS NO DIFFICULTY BREATHING, WALKED INTO OFFICE ON HER OWN POWER, AND IS TALKING.  GAVE MOM DOSING CHART FOR BENADRYL, BUT ALSO TOLD HER IF CHILD HAS ANY INCREASE IN SYMPTOMS WHATSOEVER SHE IS TO TAKE HER TO URGENT CARE OR ER.  8/5/2010 ATTEMPTED TO CALL MOM FOR FOLLOW UP.  NO ANSWER, HAD TO LEAVE VOICE MESSAGE.
This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (rash on his back that is itching a lot) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 21-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH PRURITIC (rash on his back that is itching a lot). At the time of the report, RASH PRURITIC (rash on his back that is itching a lot) had not resolved.            No concomitant medications reported. No treatment information provided.  The patient received both scheduled doses of mRNA-1273 prior to the event, therefore action taken with the drug in response to the event is not applicable.
Patient stated that symptoms of muscle aching in back of neck, shoulder and then left arm region around 2pm 12/8/04. At that time, she began to have numbness of left arm 9vaccine was given in right arm). This numbness continued but was going away by afternoon of 12/9/04.
Received third booster on 11/19/21. Appx 3 weeks pregnant at the time. Developed non-immune fetal hydrops early in pregnancy. Ultimately with severe hydrops, leading to fetal loss at 17 weeks pregnancy.
I did NOT have a Migraine after receiving the first dose of the pfizer vaccine for 3 weeks.  After receiving the second dose of the pfizer vaccine, my migraines were minimal and not bad at all.  After approximately 2-3 weeks after the second vaccine, my Migraines began coming back.  I have chronic migraines, anywhere from 1-3 week, so this was just wonderful relief even though it was temporary.  Maybe there is possibly something in this vaccine that could also help migraine sufferers.
Guillain-Barre (alleged) 11/16/07-records received for DOS 10/13-11/7/07-DC DX: Guillain Barre syndrome (acute inflammatory demyelinating polyneuropathy), status post IVIG treatments with 10 day course. Exacerbation of chronic obstructive pulmonary disease. Hypertension. Pulmonary hypertension. Schizophrenia. Depression.  Admitted with weakness, shortness of breath and hyponatremia. Severe weakness and numbness of arms and legs. Onset uncertain. Bell's phenomenon is apparent when she blinks. Weakness of orbicularis oculus muscles bilaterally. Pin sens of extremities blunted. Loss of deep tendon relexes and proprioception as well as sensation to light touch and pain. Severe sensori-motor polyneuropathy. Per 60 day follow up: Minimal residual still recovering.
Mom called stating after they returned home, patient started having a headache and complaining that her   hands and feet hurt.  she also reported that everything sounded extra loud.  Patient also had an ear wash while in the office to removed impacted ear wax.
Initial unsolicited report received from a nurse on 05-Dec-2017. This case involves a 34-year-old male patient who was vaccinated with 0.5 ml single intramuscular dose of FLUZONE QIV (Batch number: U5958AA, expiration date: 30-Jun-2018, and dose in series were not reported) in the left deltoid on 17-Nov-2017. Patient's medical history was not reported. As concomitant medications, the patient also recently was started on Hydrochlorothiazide. On an unknown date, after the vaccination, the patient had experienced symptoms of Rhabdomyolysis. On an unknown date, 10 days following the vaccination, patient required doctor visit with symptoms of Rhabdomyolysis. Laboratory investigations and corrective treatment were not reported. The outcome of the event was reported as not recovered. Upon internal review, the company decided to consider the case as serious due to important medical event: symptoms of Rhabdomyolysis. List of documents held by sender: none. Sender's Comments: This case concerns a patient who had symptoms of rhabdomyolysis post vaccination with FLUZONE QIV. Time to onset is compatible with the role of vaccine. Further information on medical history, immune status at the time of vaccination, previous vaccination and tolerance, confirmed diagnosis, laboratory investigations excluding alternative etiologies would be needed to fully assess this case. Based on available information, the role of vaccine cannot be assessed.
coughing; stuffy and runny nose; stuffy and runny nose; Increase in their mucosity and in the thickness of the mucosity; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of COUGH (coughing), RHINORRHOEA (stuffy and runny nose), NASAL CONGESTION (stuffy and runny nose) and MUCOSAL INFLAMMATION (Increase in their mucosity and in the thickness of the mucosity) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes. Concomitant products included GLIMEPIRIDE, LISINOPRIL and NIFEDIPINE for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-May-2021, the patient experienced COUGH (coughing), RHINORRHOEA (stuffy and runny nose), NASAL CONGESTION (stuffy and runny nose) and MUCOSAL INFLAMMATION (Increase in their mucosity and in the thickness of the mucosity). At the time of the report, COUGH (coughing), RHINORRHOEA (stuffy and runny nose), NASAL CONGESTION (stuffy and runny nose) and MUCOSAL INFLAMMATION (Increase in their mucosity and in the thickness of the mucosity) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   jalumex 1000 mg  is included in concomitant medication claripine, pediatric benadryl  as treatment medication
Muscles were rigid; Intense body aches; fever; Severe headache; This spontaneous case was reported by a physician and describes the occurrence of MUSCLE RIGIDITY (Muscles were rigid), MYALGIA (Intense body aches), PYREXIA (fever) and HEADACHE (Severe headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MUSCLE RIGIDITY (Muscles were rigid), MYALGIA (Intense body aches), PYREXIA (fever) and HEADACHE (Severe headache). At the time of the report, MUSCLE RIGIDITY (Muscles were rigid), MYALGIA (Intense body aches), PYREXIA (fever) and HEADACHE (Severe headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Nov-2020, SARS-CoV-2 test positive: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported by investigator o No treatment medications provided by the reporter.    This case was linked to MOD21-041645 (E2B Linked Report).; Sender's Comments:  MOD21-041645: